Output
Programmed cell death gene 4 (PDCD4), a key regulator of pancreatic beta cell survival By: Kumar, S.*; Alhasawi, N.*; Marriott, C. E.; Bone AJ and Macfarlane WM. Diabetic Medicine Volume: 32 Special Issue: SI Supplement: 1 Pages: 36-36 Meeting Abstract: P23 Published: MAR 2015
Optimisation of islet cells for transplantation therapy in Type 1 diabetes By: Alhasawi, N.*; Kumar, S.*; Bone, A. J.; Marriott C E and Macfarlane WM. Diabetic Medicine Volume: 32 Special Issue: SI Supplement: 1 Pages: 38-38 Meeting Abstract: P30 Published: MAR 2015
Protection of islet cells for transplantation therapy in Type 1 diabetes By: Alhasawi, N.*; Kumar, S.*; Marriott CE, Bone AJ and Macfarlane, W. M. Diabetic Medicine Volume: 31 Special Issue: SI Supplement: 1 Pages: 31-32 Published: MAR 2014
Differential expression of programmed cell death gene 4 (Pdcd4) and hypoxia-inducible factor 1 alpha (HIF-1alpha) in isolated human pancreatic cancer tissue, as well as in pancreatic cells in culture By: Kumar, S.*; Alhasawi, N.*; Marriott, C. E.; Bone AJ and Macfarlane WM. Diabetic Medicine Volume: 31 Special Issue: SI Supplement: 1 Pages: 33-34 Published: MAR 2014
Adaptive response of beta cells to hypoxia: regulation of cell survival and growth By: Barry, M. M.*; Bone, A. J.; Marriott, C. M.; and Macfarlane WM. Diabetic Medicine Volume: 30 Special Issue: SI Supplement: 1 Pages: 31-31 Published: MAR 2013
Expression and subcellular localisation of nuclear factor kappa B (NF-kappa B), hypoxia-inducible factor 1 alpha (HIF-1 alpha) and program cell death gene 4 (Pdcd4) in pancreatic cells in response to hypoxia By: Kumar, S.*; Marriott, C. E.; Bone, A. J.; and Macfarlane WM. Diabetic Medicine Volume: 30 Special Issue: SI Supplement: 1 Pages: 35-35 Published: MAR 2013
Funding outputs
Finance South East - Novel treatment for diabetes by generation of insulin producing cell clusters - £125,000
Business Investment Fund/CAF - Novel treatment for diabetes by generation of insulin producing cell clusters - £50,000
BBSRC CASE Studentship with Porvair Intl - Biomimetic 3D scaffolds for the cultivation and differentiation of stem cells - £65,000
EPSRC CASE studentship with Biocompatibles - A novel cell-based hypoxic model to evaluate the efficacy, toxicity and mode of action of chemoembolisation agents - £65,000
University of Brighton Innovation Award - Diabetes cause, complications and cure - £2,000
Technology outputs
Marriott, C.E., Harrison, M and Macfarlane W.M. (2008) Generation of insulin producing cell clusters using a novel cell culture system. UK Patent Number 0800524.1.
BBSRC CASE Studentship with Porvair Intl
Biomimetic 3D scaffolds for the cultivation and differentiation of stem cells.
Technology output: Directed translation of research on polymer scaffolds into product development at Porvair International, UK.